KLF4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells

Area of Science:

• Oncology
• Molecular Biology
• Cancer Stem Cell Research

Background:

• Osteosarcoma survival rates have stagnated despite advancements in chemotherapy and surgery.
• Osteosarcoma cancer stem cells (OSCs) drive tumor growth, metastasis, recurrence, and drug resistance.
• Identifying regulatory pathways of OSCs is crucial for developing improved osteosarcoma treatments.

Purpose of the Study:

• To investigate the role of Kruppel-like factor 4 (KLF4) in regulating osteosarcoma cancer stemness.
• To elucidate the molecular mechanisms by which KLF4 influences osteosarcoma progression.
• To identify potential therapeutic targets for osteosarcoma based on KLF4 function.

Main Methods:

• Assessed KLF4 expression in osteosarcoma.
• Overexpressed and knocked down KLF4 in osteosarcoma cells to evaluate its effects on stemness properties.
• Examined sphere-forming potential, stemness-associated gene expression, chemoresistance, and metastasis.
• Investigated the involvement of the p38 MAPK signaling pathway.

Main Results:

• High KLF4 expression correlated with osteosarcoma cancer stemness.
• KLF4 overexpression enhanced sphere formation, stemness markers, chemoresistance, and metastasis.
• KLF4 knockdown reduced colony formation and inhibited tumorigenesis in vivo.
• KLF4 activates the p38 MAPK pathway to promote cancer stemness.

Conclusions:

• KLF4 plays a critical role in regulating osteosarcoma cancer stem cells.
• The KLF4-p38 MAPK axis is a key pathway promoting osteosarcoma stemness and progression.
• Targeting the KLF4-p38 MAPK pathway represents a promising therapeutic strategy for osteosarcoma.